[Important] Blood-Derived Processing Service "PDF-FD" Adopted for the First Time at a National Hospital!

Waqoo Inc. (President and CEO: Bunpei Samata) is pleased to announce that our blood-derived processing service "PDF-FD" has been officially introduced at the Department of Orthopedic Surgery of the National Hospital Organization Sagamihara Hospital (hereinafter referred to as "Sagamihara Hospital"), marking our first adoption by a national hospital.

Sagamihara Hospital operates under the philosophy, "We respect the human rights of our patients and provide kind and heartfelt medical care based on sufficient explanation and consent." As an acute care general hospital with roots in a former army and national hospital, it is the most historic public hospital in the Sagamihara region.

Our company, which provides contract processing services for blood-derived products, and our subsidiary Cellpro Japan Co., Ltd., which possesses manufacturing technology, will continue to work together as a group to provide even safer services to Sagamihara Hospital. We will also strive for close collaboration with Sagamihara Hospital to contribute to the advancement of orthopedic treatment.

National Hospital Organization Sagamihara Hospital

Location 18-1 Sakuradai, Minami-ku, Sagamihara-shi, Kanagawa 252-0392 Hospital Director Ken Adachi Date Established April 1, 1938 (Independent Administrative Agency: April 1, 2004) Number of Authorized Beds General Beds: 458 (including 4 HCU beds) Homepage https://sagamihara.hosp.go.jp/index.html

About Waqoo Inc. and Cellpro Japan Co., Ltd.